Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy

被引:66
作者
Arion, D
Sabatini, M
Ungera, T
Pastor, J
Alonso-Nanclares, L
Ballesteros-Yáñez, I
Sola, RG
Muñoz, A
Mirnics, K
DeFelipe, J
机构
[1] CSIC, Inst Cajal, Madrid 28002, Spain
[2] Univ Pittsburgh, Sch Med, Dept Psychiat & Neurobiol, Pittsburgh, PA 15261 USA
[3] Hosp Princesa, Dept Neurocirugia, Madrid, Spain
关键词
temporal epilepsy; DNA microarray; transcriptome; qPCR; ictal activity; transferrin;
D O I
10.1016/j.nbd.2005.12.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The biology underlying epileptic brain activity in humans is not well understood and likely depends on changes in gene expression. We performed a microarray transcriptome profiling of 12 anterolateral temporal cortical samples originating from five individuals who suffered with temporal lobe epilepsy for at least 10 years. Prior to partial lobectomy, intraoperative electrocorticography was performed on the cortical surface of each patient. These recordings showed characteristic differences in frequency and amplitude that were defined as "spiking" (abnormal) or "non-spiking" (normal). Between the transcriptome of the two sample groups, transferrin (TF) was the most differentially expressed gene. Furthermore, gene expression profiling also revealed a downregulation of multiple GABA system-related genes (GABRA5, GABRB3, ABAT) in the spiking samples and an upregulation of oligodendrocyte and lipid metabolism transcripts (MOG, CA2, CNP, SCD, PLP1, FA2H, ABCA2). In addition, several transcripts related to the classical MAPK cascade showed expression level alterations between the spiking and non-spiking samples (G3BP2, MAPK1, PRKAR1A, and MAP4K4). Out of 12 genes chosen for verification by RT qPCR, 9 showed significant expression changes in the microarray-predicted direction. Furthermore, the microarray and qPCR data were highly correlated (r = 0.98; P < 0.001). We conclude that abnormal electrical brain activity in the spiking samples is strongly correlated with gene expression changes and we speculate that some of the observed transcriptome changes may be directly involved in the induction or prevention of the ictal events seen in epilepsy. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:374 / 387
页数:14
相关论文
共 96 条
[81]   ABCA2: a candidate regulator of neural transmembrane lipid transport [J].
Schmitz, G ;
Kaminski, WE .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (08) :1285-1295
[82]   Adenoviral gene transfer of aspartoacylase ameliorates tonic convulsions of spontaneously epileptic rats [J].
Seki, T ;
Matsubayashi, H ;
Amano, T ;
Kitada, K ;
Serikawa, T ;
Sasa, M ;
Sakai, N .
NEUROCHEMISTRY INTERNATIONAL, 2004, 45 (01) :171-178
[83]  
Skaper SD, 2001, ANN NY ACAD SCI, V939, P11
[84]   Structure and physiological function of calpains [J].
Sorimachi, H ;
Ishiura, S ;
Suzuki, K .
BIOCHEMICAL JOURNAL, 1997, 328 :721-732
[85]  
Sperk G, 2004, ADV EXP MED BIOL, V548, P92
[86]   Manganese action in brain function [J].
Takeda, A .
BRAIN RESEARCH REVIEWS, 2003, 41 (01) :79-87
[87]   Temporal and spatial profiles of ABCA2-expressing oligodendrocytes in the developing rat brain [J].
Tanaka, Y ;
Yamada, K ;
Zhou, CJ ;
Ban, N ;
Shioda, S ;
Inagaki, N .
JOURNAL OF COMPARATIVE NEUROLOGY, 2003, 455 (03) :353-367
[88]   Calpain mediates calcium-induced activation of the Erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons - Relevance to Alzheimer's disease [J].
Veeranna ;
Kaji, T ;
Boland, B ;
Odrljin, T ;
Mohan, P ;
Basavarajappa, BS ;
Peterhoff, C ;
Cataldo, A ;
Rudnicki, A ;
Amin, N ;
Li, BS ;
Pant, HC ;
Hungund, BL ;
Arancio, O ;
Nixon, RA .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (03) :795-805
[89]   Role of oleic acid as a neurotrophic factor is supported in vivo by the expression of GAP-43 subsequent to the activation of SREBP-1 and the up-regulation of stearoyl-CoA desaturase during postnatal development of the brain [J].
Velasco, A ;
Tabernero, A ;
Medina, JM .
BRAIN RESEARCH, 2003, 977 (01) :103-111
[90]   Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease [J].
Vlkolinsky, R ;
Cairns, N ;
Fountoulakis, M ;
Lubec, G .
NEUROBIOLOGY OF AGING, 2001, 22 (04) :547-553